Factors affecting medication and refill adherence among patients with asthma in Saudi Arabia: a stratified random cross-sectional study Authors: Njoud M. Alenezi, Jawad S. Alnajjar, Areej H. Alnajem, Rahmah A. Almuaybid, Zaina Abuhomoud, Mohammed H. Al Ibrahim, Karemah Alsayed, Ali Alnajim, Mohammed A. Alwosaibei, Mousa Z. Alabdullah, Fatimah Alrubaia, Qasem AlJabr Published: 2025 ABSTRACT BackgroundAsthma is a chronic respiratory disease characterized by airway inflammation, leading to varying degrees of respiratory difficulties. Effective disease management depends on consistent medication adherence, which remains a significant challenge in Saudi Arabia.ObjectiveThis study aims to assess the level of adherence to asthma medications among patients in Al-Ahsa, Saudi Arabia, and identify factors contributing to non-adherence.MethodsA cross-sectional study was conducted between may and July 2024, targeting asthma patients aged 18 years and older in Al-Ahsa. Participants were selected using a stratified random sampling technique from various geographic stria. Data were collected through structured phone interviews utilizing a validated questionnaire designed to assess adherence to medication refills. Descriptive statistics, chi-square tests, and multivariable logistic regression were used to identify factors associated with medication non-adherence.ResultsOnly 39.3% of participants were adherent to their prescribed asthma medications, while 60.7% were non-adherent. Common reasons for non-adherence included stopping medications when feeling better (36.9%) and stopping medication due to side effects (20.4%). Female gender (p = 0.021), higher income (p = 0.034), being married (p = 0.049), urban residence (p = 0.001), and receiving medication support (p < 0.001) were significantly associated with higher adherence. Multivariable regression showed that younger age (OR = 0.97; 95% CI: 0.95–0.98), male gender (OR = 1.76; 95% CI: 1.16–2.69), lower income (OR = 0.85; 95% CI: 0.75–0.97), and lack of medication support (OR = 0.06; 95% CI: 0.04–0.10) were independently associated with non-adherence.ConclusionMedication non-adherence is prevalent among asthma patients in Al-Ahsa and is influenced by demographic, socioeconomic, and healthcare-related factors. Interventions targeting support systems, education, and access may enhance adherence and improve asthma outcomes in this population. Introduction Asthma is a heterogeneous chronic respiratory disease characterized by persistent airway inflammation, resulting in variable respiratory symptoms and airflow limitation (https://ginasthma.org/wp-content/uploads/2024/05/GINA-2024-Strategy-Report-24_05_22_WMS.pdf). Common clinical manifestations include coughing, wheezing, shortness of breath, and chest tightness, which vary in frequency and severity over time [1]. Asthma can be classified into several phenotypes based on pathological features, such as allergic asthma, non-allergic asthma, cough variant asthma, adult-onset asthma, asthma with persistent airflow limitation, and asthma associated with obesity (https://ginasthma.org/wp-content/uploads/2024/05/GINA-2024-Strategy-Report-24_05_22_WMS.pdf). Diagnosis is primarily based on a clinical history of characteristic respiratory symptoms, supported by objective evidence of variable expiratory airflow limitation (https://ginasthma.org/wp-content/uploads/2024/05/GINA-2024-Strategy-Report-24_05_22_WMS.pdf). According to the World Health Organization, asthma affected approximately 262 million individuals globally in 2019 [1]. Each year, an estimated 2.5 million deaths are attributed to severe asthma exacerbations [2]. In Saudi Arabia, the prevalence of asthma ranges between 15 and 25% [3]. Asthma is incurable but can be effectively managed through both pharmacological and non-pharmacological strategies [1]. Pharmacological interventions include inhaled corticosteroids, long-acting and short-acting beta-2 agonists, and long-acting antimuscarinics, used for both maintenance therapy and symptom relief (https://ginasthma.org/wp-content/uploads/2024/05/GINA-2024-Strategy-Report-24_05_22_WMS.pdf). Non-pharmacological strategies such as smoking cessation, regular physical activity, and allergen avoidance also contribute to disease control. Medication adherence plays a crucial role in achieving optimal asthma management and reducing morbidity and mortality [4, 5]. Poor adherence to asthma medications is associated with adverse outcomes, including increased symptom burden, psychological distress, frequent exacerbations, higher healthcare costs, and reduced quality of life [4, 6, 7]. Two systematic reviews have demonstrated that good adherence to asthma controller therapy is consistently associated with a lower risk of severe exacerbations, whereas poor adherence or discontinuation of treatment is linked to a significantly increased risk [8]. Although numerous international studies have examined the factors influencing asthma medication adherence, there remains a lack of research tailored to the Saudi population [9, 10]. No published studies have assessed adherence specifically within the Al-Ahsa region. Therefore, the present study aimed to evaluate the level of medication adherence among asthma patients in Al-Ahsa and to identify the key barriers contributing to non-adherence. Materials and methods Study design, setting, and participants A cross-sectional study was conducted from May to July 2024 using a Stratified random sampling technique and structured telephone interviews. Eligible participants were individuals aged 18 years or older, residing in Al-Ahsa, Saudi Arabia, with a confirmed diagnosis of asthma between February 2023 and April 2024. Exclusion criteria included individuals under the age of 18, those diagnosed outside the specified time frame, and those without a confirmed asthma diagnosis. As illustrated in (Fig. 1), Primary Health Care Centers (PHCs) in Al-Ahsa were categorized into four geographic strata: Eastern, Middle, Northern, and Southern. A Stratified random sampling technique was employed, with each stratum assigned a proportional sample size based on population distribution. Within each stratum, patients were selected using a randomization process from existing patient rolls. The required sample size for each stratum was calculated using the formula for a single population proportion, based on the following assumptions: Z = 1.96 (corresponding to a 95% confidence level), margin of error (E) = 0.05, and expected proportion (P) = 50% (Table 1).Fig. 1Overview of the data collection and sampling techniqueTable 1Calculated sample size for each geographic StratumGeographic StratumAsthmatic population (N)Sample size (n)Eastern426203Middle526223Northern430204Southern247151 Overview of the data collection and sampling technique Table 1Calculated sample size for each geographic StratumGeographic StratumAsthmatic population (N)Sample size (n)Eastern426203Middle526223Northern430204Southern247151 Calculated sample size for each geographic Stratum Questionnaire development and data collection The questionnaire was administered via phone interviews between May and July 2024, beginning with obtaining informed consent from participants. The initial section of the data collection focused on gathering demographic information, including age, gender, residency, and socioeconomic factors such as occupation, income, and family medical history. Additionally, participants provided details about their education level, employment status, and marital status. The health and medical history section included questions on general health conditions, height, weight, and any previous diagnoses of chronic illnesses. Lastly, asthma-specific information was collected, covering the onset of the condition, its duration, and the yearly frequency of asthma attacks. The final section of the questionnaire focused on adherence to medications and refills, using the validated Arabic version of the Adherence to Refills and Medications Scale (ARMS) developed by Alammari et al. [11]. The ARMS is a 12-item self-reported scale originally developed in English, comprising two subscales: adherence to medication refills and adherence to medication-taking behavior. Ethical consideration and statistical analysis Before conducting the study, participants were provided with informed consent forms. In compliance with ethical standards for research involving human participants, all data were kept confidential and used solely for research purposes. This study was approved by the King Fahad Hospital-Al-Hofuf Ethics Committee (IRB-KFHH No. H-05-HS-065). Data analysis Data analysis for this study was performed using SPSS version 27 (IBM Corp., 2020). Descriptive statistics were employed to present the characteristics of the study population, including demographic, health profile, and adherence-related variables specific to asthma patients. Continuous variables, such as age and the duration of asthma, were summarized using the mean and standard deviation, while categorical variables, including gender, region, marital status, and asthma treatment, were summarized with frequencies and percentages. To examine factors influencing medication adherence and refill behaviors, bivariate analyses, including Pearson's Chi-square test, were conducted to explore relationships between independent variables (e.g., demographics, asthma control, and healthcare access) and the dependent variable of medication adherence. Significant associations identified through bivariate tests were further investigated using multiple logistic regression to identify predictors of non-adherence to medications and refill behaviors. Adjusted odds ratios (OR) and confidence intervals (CI) were reported to evaluate the strength and direction of these relationships. A p-value less than 0.05 was considered statistically significant. Results Eight hundred ninety-nine participants were included in the study (Table 2)/72.97% have at least one or more chronic diseases, of which the most common were respiratory diseases (33.82%), followed by diabetes (30.14%) and hypertension (29.14%). In terms of BMI, only 1.67% of the subjects were underweight, while 29.70% were overweight, and 47.05% had obesity. Regarding exercise habits, 35.48% of participants reported not doing any sports, 21.91% exercised less than 60 min per week, 25.47% exercised 60–150 min per week, and 17.13% exercised more than 150 min per week. Only 11.12% reporting current smoking. Additionally, 62.18% had a family history of asthma, while 37.82% did not.Table 2Health characteristics (N = 899)VariableFreq. (%)Chronic Diseases (multiplicity possible) Hypertension262 (29.14) Hyper/Hypothyroidism72 (8.01) Vascular and heart diseases91 (10.12) Psychological diseases such as obsessive–compulsive disorder and others70 (7.79) Respiratory diseases304 (33.82) Diseases of the digestive system such as Inflammatory bowel disease and others121 (13.46) Rheumatic diseases, osteoarthritis, and others77 (8.57) Skin diseases such as psoriasis, vitiligo, and others42 (4.67) Diabetes Mellitus271 (30.14) Other52 (5.78) None243 (27.03)BMI Underweight15(1.67) Healthy Weight194(21.58) Overweight267(29.70) Obesity423(47.05)Exercise per week I don't do any sports319(35.48) Less than 60 min197(21.91) 60—150 min229(25.47) More than 150 min154(17.13)Smoking No799(88.88) Yes100(11.12)Family history of Asthma No340(37.82) Yes559(62.18) Table 2Health characteristics (N = 899)VariableFreq. (%)Chronic Diseases (multiplicity possible) Hypertension262 (29.14) Hyper/Hypothyroidism72 (8.01) Vascular and heart diseases91 (10.12) Psychological diseases such as obsessive–compulsive disorder and others70 (7.79) Respiratory diseases304 (33.82) Diseases of the digestive system such as Inflammatory bowel disease and others121 (13.46) Rheumatic diseases, osteoarthritis, and others77 (8.57) Skin diseases such as psoriasis, vitiligo, and others42 (4.67) Diabetes Mellitus271 (30.14) Other52 (5.78) None243 (27.03)BMI Underweight15(1.67) Healthy Weight194(21.58) Overweight267(29.70) Obesity423(47.05)Exercise per week I don't do any sports319(35.48) Less than 60 min197(21.91) 60—150 min229(25.47) More than 150 min154(17.13)Smoking No799(88.88) Yes100(11.12)Family history of Asthma No340(37.82) Yes559(62.18) Health characteristics (N = 899) Regarding medication adherence (Table 3), a significant portion of patients report issues such as forgetting to take their medication (4.8% most times, 1.4% always), deciding not to take their medication (3.8% most times, 1.8% always), and forgetting to refill medications (5.5% most times, 0.8% always). The data also reveals that many patients miss their medications due to a perceived improvement in their condition—11.6% report missing their medications "most times" when feeling better, and 14.3% do so "always." However, 90.4% report missing medications "never" when feeling sick, highlighting a clear trend of adherence in these instances. When it comes to refills, a larger proportion of patients (16.5%) refill their medications "most times," and 39.4% "always" refill before their medications run out, suggesting that many patients are attentive to maintaining a continuous supply of their medications.Table 3Adherence to medication and refill among asthma patients (N = 899)ItemsNeverSometimesMost timesAlwaysNo%No%No%No%Forget to take your meds55361.5%29032.3%434.8%131.4%Decide not to take your meds60867.6%24126.8%343.8%161.8%Forget to refill your meds68075.6%16318.1%495.5%7.8%Run out of meds66473.9%19621.8%353.9%4.4%Skip a dose without dr consult67975.5%15917.7%455.0%161.8%Miss meds when feel better48453.8%18220.2%10411.6%12914.3%Miss meds when feel sick81390.4%808.9%2.2%4.4%Miss meds due to careless69977.8%17719.7%182.0%5.6%Change meds dose to suit your needs63070.1%23225.8%333.7%4.4%Forget meds that you supposed to take more than 1 a day57263.6%29933.3%252.8%3.3%Put off your meds due to high cost77085.7%11713.0%111.2%1.1%Refill before meds run out28431.6%11312.6%14816.5%35439.4% Table 3Adherence to medication and refill among asthma patients (N = 899)ItemsNeverSometimesMost timesAlwaysNo%No%No%No%Forget to take your meds55361.5%29032.3%434.8%131.4%Decide not to take your meds60867.6%24126.8%343.8%161.8%Forget to refill your meds68075.6%16318.1%495.5%7.8%Run out of meds66473.9%19621.8%353.9%4.4%Skip a dose without dr consult67975.5%15917.7%455.0%161.8%Miss meds when feel better48453.8%18220.2%10411.6%12914.3%Miss meds when feel sick81390.4%808.9%2.2%4.4%Miss meds due to careless69977.8%17719.7%182.0%5.6%Change meds dose to suit your needs63070.1%23225.8%333.7%4.4%Forget meds that you supposed to take more than 1 a day57263.6%29933.3%252.8%3.3%Put off your meds due to high cost77085.7%11713.0%111.2%1.1%Refill before meds run out28431.6%11312.6%14816.5%35439.4% Adherence to medication and refill among asthma patients (N = 899) Figure 2 illustrates the adherence rate to medication refills among asthma patients in Saudi Arabia, based on a sample of 899 individuals. The data reveal that 39.3% (353 patients) of the participants are considered adherent to their prescribed asthma medication regimen, while the majority, 60.7% (546 patients), are non-adherent.Fig. 2Asthma patients' adherence rate to refill and medications (N = 899) Asthma patients' adherence rate to refill and medications (N = 899) Figure 3 illustrates the reasons that reduce asthma patients' commitment to taking their medications in Saudi Arabia. Among the 899 participants, 39.3% (353 patients) reported no specific reasons for reduced commitment. The most common reason was stopping medication when feeling well, reported by 36.9% (332 patients). On the other hand, only a very small percentage (0.3%, 3 patients) reported a lack of family support as a factor affecting their adherence.Fig. 3Reasons that reduce your commitment to taking medication among Asthma patients Reasons that reduce your commitment to taking medication among Asthma patients Tables 4 and 5 reveals several statistically significant factors (p < 0.05) influencing asthma medication adherence. Higher adherence was observed in patients from the Southern region (65.7%, p = 0.001), females (42.4%, p = 0.021), those with higher monthly incomes (56.3%, p = 0.034), divorced/widowed individuals (42.9%, p = 0.049), those with secondary/diploma education level (45.5%, p = 0.001), employed individuals (≥ 34.1%, p = 0.001), residents of downtown areas (42.1%, p = 0.001), patients with a family history of asthma (42.2%, p = 0.02), those with co-morbidities (41.8%, p = 0.012), and individuals with a shorter asthma duration (50.5%, p = 0.001). Interestingly, patients on more medications (3 or more, p = 0.001) and those on maintenance therapy (p = 0.001) showed higher adherence. Furthermore, more frequent doctor visits (p = 0.001), receiving medication information from their physician (p = 0.003), and having medication support (p = 0.001) were also strongly linked to better adherence.Table 4Factors associated with asthma patients' re-fill and medication adherenceFactorsAdherencep-valueAdherentNon-AdherentNo%No%RegionEastern9034.6%17065.4%.001*Middle2812.0%20588.0%Northern12252.1%11247.9%Southern11365.7%5934.3%Age in years< 303931.7%8468.3%.001*30–394629.9%10870.1%40–497333.0%14867.0%50–599148.1%9851.9%60 + 10449.1%10850.9%GenderMale12934.8%24265.2%.021*Female22442.4%30457.6%Body mass indexNormal weight7837.3%13162.7%.718Overweight10138.3%16361.7%Obesity class I7238.1%11761.9%Obesity class II5644.1%7155.9%Obesity class III4641.8%6458.2%Monthly income< 5000 SR11735.1%21664.9%.034*5000–10000 SR13144.9%16155.1%10,000–20000 SR4542.1%6257.9%> 20,000 SR956.3%743.8%Unknown5133.8%10066.2%Marital statusSingle3929.8%9270.2%.049*Married26040.5%38259.5%Divorce/widow5442.9%7257.1%Educational levelIlliterate3640.9%5259.1%.001*Basic education12643.4%16456.6%Secondary/diploma15245.5%18254.5%Bachelor degree2917.8%13482.2%Post-graduate degree1041.7%1458.3%EmploymentUnemployed10832.4%22567.6%.001*Student1428.0%3672.0%Non- medical job18546.1%21653.9%Medical job1756.7%1343.3%Retired2934.1%5665.9%ResidenceDowntown31342.1%43157.9%.001*^Rural area2922.8%9877.2%Immigration area1139.3%1760.7%P Pearson X2 test^Exact probability test*P < 0.05 (significant)Table 5Factors associated with asthma patient's re-fill and medication adherenceFactorsAdherencep-valueAdherentNon-AdherentNo%No%Do you have a family history of AsthmaYes23642.2%32357.8%.020*No11734.4%22365.6%Other co-morbiditiesNo7932.5%16467.5%.012*Yes27441.8%38258.2%Duration of Asthma in years< 5 years10250.5%10049.5%.001*5–10 years12349.2%12750.8%11–20 years6334.8%11865.2%> 20 years6524.4%20175.6%SmokingYes2929.0%7171.0%.026*No32440.6%47559.4%Number of received medications1.005022.1%17677.9%.001*^2.006830.9%15269.1%3.0013261.4%8338.6%4.007954.1%6745.9%5.001440.0%2160.0%6 + 1017.5%4782.5%Are you on maintenance therapy for asthma?Yes28142.6%37957.4%.001*No7230.1%16769.9%How many times do you visit the doctor during the year?Once a year4627.4%12272.6%.001*Twice (every 6 months)7639.2%11860.8%Three times (every 4 months)15455.0%12645.0%More than three times a year7730.0%18070.0%Did your physician gives your information about Anti-asthma medications?Yes31641.3%45058.7%.003*No3727.8%9672.2%Do you have someone who helps you take medications?Yes24673.9%8726.1%.001*No10718.9%45981.1%P Pearson X2 test^Exact probability test*P < 0.05 (significant) Table 4Factors associated with asthma patients' re-fill and medication adherenceFactorsAdherencep-valueAdherentNon-AdherentNo%No%RegionEastern9034.6%17065.4%.001*Middle2812.0%20588.0%Northern12252.1%11247.9%Southern11365.7%5934.3%Age in years< 303931.7%8468.3%.001*30–394629.9%10870.1%40–497333.0%14867.0%50–599148.1%9851.9%60 + 10449.1%10850.9%GenderMale12934.8%24265.2%.021*Female22442.4%30457.6%Body mass indexNormal weight7837.3%13162.7%.718Overweight10138.3%16361.7%Obesity class I7238.1%11761.9%Obesity class II5644.1%7155.9%Obesity class III4641.8%6458.2%Monthly income< 5000 SR11735.1%21664.9%.034*5000–10000 SR13144.9%16155.1%10,000–20000 SR4542.1%6257.9%> 20,000 SR956.3%743.8%Unknown5133.8%10066.2%Marital statusSingle3929.8%9270.2%.049*Married26040.5%38259.5%Divorce/widow5442.9%7257.1%Educational levelIlliterate3640.9%5259.1%.001*Basic education12643.4%16456.6%Secondary/diploma15245.5%18254.5%Bachelor degree2917.8%13482.2%Post-graduate degree1041.7%1458.3%EmploymentUnemployed10832.4%22567.6%.001*Student1428.0%3672.0%Non- medical job18546.1%21653.9%Medical job1756.7%1343.3%Retired2934.1%5665.9%ResidenceDowntown31342.1%43157.9%.001*^Rural area2922.8%9877.2%Immigration area1139.3%1760.7%P Pearson X2 test^Exact probability test*P < 0.05 (significant) Factors associated with asthma patients' re-fill and medication adherence P Pearson X2 test ^Exact probability test *P < 0.05 (significant) Table 5Factors associated with asthma patient's re-fill and medication adherenceFactorsAdherencep-valueAdherentNon-AdherentNo%No%Do you have a family history of AsthmaYes23642.2%32357.8%.020*No11734.4%22365.6%Other co-morbiditiesNo7932.5%16467.5%.012*Yes27441.8%38258.2%Duration of Asthma in years< 5 years10250.5%10049.5%.001*5–10 years12349.2%12750.8%11–20 years6334.8%11865.2%> 20 years6524.4%20175.6%SmokingYes2929.0%7171.0%.026*No32440.6%47559.4%Number of received medications1.005022.1%17677.9%.001*^2.006830.9%15269.1%3.0013261.4%8338.6%4.007954.1%6745.9%5.001440.0%2160.0%6 + 1017.5%4782.5%Are you on maintenance therapy for asthma?Yes28142.6%37957.4%.001*No7230.1%16769.9%How many times do you visit the doctor during the year?Once a year4627.4%12272.6%.001*Twice (every 6 months)7639.2%11860.8%Three times (every 4 months)15455.0%12645.0%More than three times a year7730.0%18070.0%Did your physician gives your information about Anti-asthma medications?Yes31641.3%45058.7%.003*No3727.8%9672.2%Do you have someone who helps you take medications?Yes24673.9%8726.1%.001*No10718.9%45981.1%P Pearson X2 test^Exact probability test*P < 0.05 (significant) Factors associated with asthma patient's re-fill and medication adherence P Pearson X2 test ^Exact probability test *P < 0.05 (significant) Table 6 presents the results of a multiple logistic regression model for identifying predictors of asthma patients' medication non-adherence. Several factors were found to significantly influence adherence behavior. Patients from the Northern region were significantly more likely to be non-adherent compared to those from the Southern region, with an odds ratio (ORA) of 5.97 (95% CI: 3.18–11.18) and a p-value of 0.001, indicating a strong regional effect. Similarly, patients from the Western region had higher odds of non-adherence compared to those in the Southern region, with an ORA of 1.71 (95% CI: 1.02–2.86) and a p-value of 0.043. Age was also a significant factor, with younger patients being more likely to be non-adherent; for each year increase in age, the odds of non-adherence decreased by 3% (ORA = 0.97, 95% CI: 0.95–0.98), with a p-value of 0.001. Gender also played a role, as males were found to have higher odds of non-adherence than females, with an ORA of 1.76 (95% CI: 1.16–2.69) and a p-value of 0.008. Higher monthly income was associated with a lower likelihood of non-adherence, as those with higher incomes had an ORA of 0.85 (95% CI: 0.75–0.97) and a p-value of 0.018. Unmarried patients were more likely to be non-adherent compared to married individuals, with an ORA of 1.53 (95% CI: 1.03–2.27) and a p-value of 0.036. The duration of asthma also affected adherence, with a slight decrease in the likelihood of non-adherence as the duration of asthma increased (ORA = 0.98, 95% CI: 0.96–0.99), and a p-value of 0.008. Finally, the most significant predictor was having help with taking medications, as patients who received assistance were much less likely to be non-adherent, with an ORA of 0.06 (95% CI: 0.04–0.10) and a p-value of 0.000, emphasizing the importance of support in improving adherence.Table 6Multiple logistic regression model for predictors of asthma patients' medications non-adherencePredictorsp-valueORA95% CILowerUpperRegion Eastern vs. Southern.5391.200.672.17 Northern vs. Southern.001*5.973.1811.18 Western vs. Southern.043*1.711.022.86Age in years.001*0.970.950.98Male vs. Female.008*1.761.162.69Higher monthly income.018*0.850.750.97unmarried vs. married.036*1.531.032.27Duration of asthma.008*0.980.960.99Had some help to have medications.000*0.060.040.10ORA Adjusted odds ratioCI Confidence interval*P < 0.05 (significant) Table 6Multiple logistic regression model for predictors of asthma patients' medications non-adherencePredictorsp-valueORA95% CILowerUpperRegion Eastern vs. Southern.5391.200.672.17 Northern vs. Southern.001*5.973.1811.18 Western vs. Southern.043*1.711.022.86Age in years.001*0.970.950.98Male vs. Female.008*1.761.162.69Higher monthly income.018*0.850.750.97unmarried vs. married.036*1.531.032.27Duration of asthma.008*0.980.960.99Had some help to have medications.000*0.060.040.10ORA Adjusted odds ratioCI Confidence interval*P < 0.05 (significant) Multiple logistic regression model for predictors of asthma patients' medications non-adherence ORA Adjusted odds ratio CI Confidence interval *P < 0.05 (significant) Discussion This study is the first to assess medication and refill adherence among asthma patients in the Al-Ahsa region of Saudi Arabia. It aimed to identify variables associated with adherence behaviors in this population. Medication non-adherence is a complicated, diverse health care issue. The World Health Organization (WHO) states that adherence is impacted by variables which involve patients' circumstances, therapy, health problems, health care systems, as well socioeconomic position [12]. A range of fifty to sixty percent of patients, particularly those with long-term conditions, do not take the drugs they were prescribed according to instructions [13]. Medication waste, the development of medical conditions, a decrease in functional abilities, a lower quality of life, and a spike in demand for medical services such as hospital stays, visits, and admissions are just a few of the negative effects of non-adherence [4]. The study revealed that 60.7% of participants were non adherent to their asthma medication, with an overall adherence rate of 39.3%. The majority of participants were female, which aligns with findings from previous studies [7]. Similarly, our results are consistent with a Saudi-based study by Alqarni et al., which reported poor medication adherence among asthma patients in the western region of the country [7]. Comparable trends of high nonadherence rates have been observed in studies conducted in Kuwait (82.6%), Northwestern Ethiopia (86.1%), Bangladesh (86%), Tanzania (60.3%), and Northern Ireland (88%) [14–17]. Additionally, a study by Bassam et al. assessing medication adherence among adult asthma patients in the Middle East and North Africa (MENA) region found that fewer than one-quarter of participants demonstrated good adherence. Notably, higher adherence rates were observed in Qatar, Lebanon, and the United Arab Emirates, while lower adherence rates were reported in Iraq and Jordan [18]. Furthermore, the primary barriers to medication adherence identified in our study were discontinuation of medication upon symptom improvement and forgetfulness. These findings are consistent with those reported in previous literature [18]. Factors assessed for their contribution to non-adherence included age, gender, marital status, income level, educational level, employment status, place of residence, occupation, region, presence of chronic diseases, smoking status, family history of asthma, number of medications used, duration of therapy, and type of asthma medication. Participants with unknown monthly income and income of less than 5,000 SAR demonstrated lower adherence (66.2%,64.9%) respectively, which differs from a previous study that reported the lowest adherence among patients receiving monthly financial support of 5,000 SAR or less counted 69.3% [19]. Additionally, illiterate participants and those with a bachelor’s degree exhibited lower adherence, contradicting findings from another study that reported reduced adherence among participants with secondary and higher education levels [20]. Unemployed participants and students in our study showed lower adherence, in contrast to a prior study that identified the lowest adherence levels among employed individuals [15]. In line with previous findings, our study showed that smoking participants had lower adherence to asthma medications compared to non-smokers [15]. A higher adherence rate was observed among participants with a positive family history of asthma, consistent with a study conducted in Japan that demonstrated an association between family history and improved adherence [21]. Additionally, our results indicated that participants with a disease duration of more than 20 years had the lowest adherence, whereas a prior study found the lowest adherence level was among individuals with an asthma duration of 8 years or less [20]. Strengths of the study include the use of stratified random sampling across multiple geographic strata in Al-Ahsa and structured telephone interviews, which enhanced the representativeness of the findings. Limitations include the self-reported nature of adherence measures, potential recall bias, and the cross-sectional design which limits causal inference. Our findings emphasize the need for targeted interventions addressing specific barriers such as forgetfulness and symptom-based discontinuation. Health education programs and medication reminders may enhance adherence. Further longitudinal studies are recommended to explore causality and assess the effectiveness of tailored adherence interventions across different socioeconomic and clinical subgroups. Conclusion The findings of this study highlight significant challenges in medication adherence among asthma patients in Al-Ahsa, Saudi Arabia, with over 60% of the population not adhering to their prescribed medications. Several factors, including gender, age, income, exercise habits, and the duration of asthma therapy, were found to influence adherence rates. Additionally, common reasons for non-adherence included stopping medication due to feeling well, experiencing side effects, and forgetting to take the medication. These results emphasize the need for targeted interventions that address these barriers, such as improving patient education, enhancing follow-up care, and providing support for long-term medication management. Addressing these factors is essential for improving disease control, reducing exacerbations, and enhancing the quality of life for asthma patients in the region.